Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126574511 | 12657451 | 1 | I | 20140227 | 20160804 | 20160816 | 20160816 | EXP | ES-AGEMED-140123540 | ES-ELI_LILLY_AND_COMPANY-ES201608008107 | ELI LILLY AND CO | 66.00 | YR | M | Y | 0.00000 | 20160816 | CN | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126574511 | 12657451 | 1 | PS | Prasugrel Hydrochloride | PRASUGREL HYDROCHLORIDE | 1 | Oral | 10 MG, QD | 22307 | 10 | MG | TABLET | QD | ||||||
| 126574511 | 12657451 | 2 | SS | Prasugrel Hydrochloride | PRASUGREL HYDROCHLORIDE | 1 | 22307 | TABLET | |||||||||||
| 126574511 | 12657451 | 3 | SS | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 126574511 | 12657451 | 4 | SS | ACETYLSALICYLIC ACID | ASPIRIN | 1 | 0 | ||||||||||||
| 126574511 | 12657451 | 5 | SS | ENALAPRIL | ENALAPRIL | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 126574511 | 12657451 | 6 | SS | OMEPRAZOL /00661201/ | OMEPRAZOLE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 126574511 | 12657451 | 7 | SS | EPLERENONA | EPLERENONE | 1 | Oral | 25 MG, QD | Y | 0 | 25 | MG | QD | ||||||
| 126574511 | 12657451 | 8 | SS | EPLERENONA | EPLERENONE | 1 | Y | 0 | |||||||||||
| 126574511 | 12657451 | 9 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 80 MG, QD | 0 | 80 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126574511 | 12657451 | 1 | Myocardial infarction |
| 126574511 | 12657451 | 2 | Myocardial ischaemia |
| 126574511 | 12657451 | 3 | Myocardial infarction |
| 126574511 | 12657451 | 4 | Myocardial ischaemia |
| 126574511 | 12657451 | 5 | Hypertension |
| 126574511 | 12657451 | 6 | Prophylaxis |
| 126574511 | 12657451 | 7 | Myocardial infarction |
| 126574511 | 12657451 | 8 | Myocardial ischaemia |
| 126574511 | 12657451 | 9 | Hyperlipidaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126574511 | 12657451 | HO |
| 126574511 | 12657451 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126574511 | 12657451 | Acute kidney injury | |
| 126574511 | 12657451 | Hyperkalaemia | |
| 126574511 | 12657451 | Hypersensitivity vasculitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126574511 | 12657451 | 1 | 20140214 | 0 | ||
| 126574511 | 12657451 | 3 | 20140214 | 0 | ||
| 126574511 | 12657451 | 5 | 20140214 | 0 | ||
| 126574511 | 12657451 | 6 | 20140214 | 0 | ||
| 126574511 | 12657451 | 7 | 20140214 | 20140228 | 0 | |
| 126574511 | 12657451 | 9 | 20140214 | 0 |